CDK6 and cancer: Low-risk hsa-miR-29c miRNA targeted three downregulated mRNA genes, BCL11A (logFC −3.26), COL22A1 (logFC −3.56), involved in the regulation of important processes such as structural molecular activity and extracellular region; CDK6 (logFC −2.09), involved in multiple pathways of cancer, p53 signaling pathway, cell cycle regulation, and the positive and negative regulation of cell proliferation.